Zongwei Li
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
IRF4 in multiple myeloma: From molecular mechanisms to therapeutic targeting.
Journal: Cellular signalling
Published: July 09, 2026
Corrigendum to "Liquiritigenin targets transferrin receptor to potentiate ferroptosis sensitivity in colorectal cancer cells" [Phytomedicine. 154 (2026) 158057].
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 29, 2026
Liquiritigenin targets transferrin receptor to potentiate ferroptosis sensitivity in colorectal cancer cells.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 04, 2025
AFF4 promotes tumor progression and cisplatin resistance by modulating the PTEN/PI3K/AKT/mTOR axis to accelerate glycolysis in lung adenocarcinoma.
Journal: Cell & bioscience
Published: February 17, 2025
Chemotherapy-Mediated Induction of PD-L1 via SEI1 Facilitates Myeloma Immune Evasion.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 12, 2024
EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction.
Journal: Nature communications
Published: April 11, 2024
IDO1-mediated kynurenine production inhibits IGFBP5 signaling to promote 5-fluorouracil-induced senescence escape and chemoresistance in colorectal cancer.
Journal: American journal of cancer research
Published: April 07, 2024
Avenanthramide A potentiates Bim-mediated antineoplastic properties of 5-fluorouracil via targeting KDM4C/MIR17HG/GSK-3β negative feedback loop in colorectal cancer.
Journal: Acta pharmaceutica Sinica. B
Published: February 20, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026